• LAST PRICE
    16.8300
  • TODAY'S CHANGE (%)
    Trending Down-1.1500 (-6.3960%)
  • Bid / Lots
    16.6500/ 10
  • Ask / Lots
    16.9200/ 1
  • Open / Previous Close
    17.5900 / 17.9800
  • Day Range
    Low 16.5900
    High 18.1000
  • 52 Week Range
    Low 11.8500
    High 78.7500
  • Volume
    40,479
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 17.98
TimeVolumePRAX
09:32 ET180517.6
09:35 ET10817.7798
09:51 ET20017.76
10:00 ET56017.3135
10:06 ET33517.6309
10:11 ET10017.69
10:13 ET10017.75
10:18 ET10017.81
10:20 ET30017.82
10:24 ET43517.57
10:36 ET20017.57
10:40 ET10017.525
10:44 ET39817.44
10:45 ET41017.6337
11:02 ET10017.465
11:07 ET30017.34
11:12 ET20317.3
11:18 ET20017.31
11:20 ET20017.31
11:34 ET10017.165
11:45 ET10017.12
11:50 ET55216.86
11:54 ET20016.86
11:56 ET69516.7
11:59 ET20016.595
12:01 ET127616.725
12:28 ET30016.868
12:30 ET35016.93
12:37 ET10016.93
12:44 ET40717
12:48 ET10017
12:51 ET40017
12:53 ET10017
12:55 ET70016.99
01:02 ET10017.17
01:06 ET110017.07
01:09 ET16616.9943
01:15 ET33016.9339
01:27 ET13316.6801
01:49 ET10016.83
01:51 ET68416.85
02:00 ET75016.9233
02:03 ET79016.7
02:07 ET10016.86
02:25 ET20016.77
02:34 ET10016.88
02:45 ET29616.88
02:57 ET10016.94
03:19 ET10017
03:21 ET20017
03:24 ET10016.9401
03:30 ET35716.95
03:32 ET10016.92
03:35 ET30816.93
03:37 ET10016.92
03:44 ET10016.9
03:46 ET10016.835
03:48 ET20016.9
03:51 ET130916.91
03:53 ET20016.87
03:55 ET36016.81
03:57 ET150016.825
04:00 ET75816.83
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPRAX
Praxis Precision Medicines Inc
144.2M
-0.5x
---
United StatesNVCT
Nuvectis Pharma Inc
141.9M
-5.6x
---
United StatesXFOR
X4 Pharmaceuticals Inc
147.3M
-1.1x
---
United StatesANNX
Annexon Inc
141.1M
-1.4x
---
United StatesDNTH
Dianthus Therapeutics Inc
140.8M
-0.6x
---
United StatesVOR
Vor Biopharma Inc
149.2M
-1.2x
---
As of 2023-12-10

Company Information

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalances. The Company is applying genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small molecule platform, which utilizes understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally precision therapies; and Solidus, is an antisense oligonucleotide (ASO) platform, which targets precision medicine discovery and development engine anchored on a proprietary, computational methodology. Its product candidates include PRAX-944, PRAX-562, PRAX-628 and PRAX-222.

Contact Information

Headquarters
99 High Street, 30th FloorBOSTON, MA, United States 02110
Phone
617-300-8460
Fax
302-655-5049

Executives

Independent Chairman of the Board
Dean Mitchell
President, Chief Executive Officer, Director
Marcio Souza
Chief Financial Officer
Timothy Kelly
General Counsel, Corporate Secretary
Alex Nemiroff
Independent Director
Jeffrey Chodakewitz

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$144.2M
Revenue (TTM)
$1.9M
Shares Outstanding
8.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-33.65
Book Value
$23.12
P/E Ratio
-0.5x
Price/Sales (TTM)
74.7
Price/Cash Flow (TTM)
---
Operating Margin
-7,247.41%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.